What does my Cholangiocarcinoma biomarker profile mean for treatment options

CholangiocarcinomaMay 22, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Cholangiocarcinoma Biomarker Profile

I'd be happy to help you understand what your biomarkers mean for treatment planning. However, I notice you haven't shared your specific test results or biomarker profile yet.

To give you the most helpful educational interpretation, I'll need you to upload or share:

  • Your pathology report (showing tumor characteristics)
  • Any molecular testing results (genetic/biomarker tests like MSI, TMB, KRAS, BRCA, etc.)
  • Imaging reports (CT, MRI, or PET scans)
  • Lab values or other relevant test results

Once you share these documents, I can help you understand:

  • What each biomarker means in plain language
  • How doctors typically use these findings to guide treatment decisions
  • What treatment approaches are generally considered for your specific profile
  • Questions you should ask your oncology team

Why Biomarkers Matter for Cholangiocarcinoma

Cholangiocarcinoma (bile duct cancer) treatment has evolved significantly because doctors now test for specific molecular features that predict which treatments will work best. According to NCCN Guidelines for Cholangiocarcinoma, biomarker testing is increasingly important for identifying patients who may benefit from targeted therapies beyond standard chemotherapy.

**Please upload your [ID removed] and I'll provide a detailed, educational explanation of what your results mean and help you prepare questions for your care team.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: